CALMARK SWEDEN AB Inactive Instrument
Calmark Sweden AB Stock
Equities
CALMA B
SE0011116524
Advanced Medical Equipment & Technology
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Camilla Arneving
CEO | Chief Executive Officer | - | 18-08-31 |
| Founder | 52 | 06-12-31 | |
Peter Larsson
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 17-12-31 | |
| Founder | 52 | 06-12-31 | |
| Chairman | 52 | 17-12-31 |
Calmark Sweden AB is a Sweden-based Company providing patient-near-term testing (PNA) specialized in newborns. Its main focus is to develop medical diagnostic biotechnology. The Company focuses on the development of solutions for point-of-care detection of critical illness. Calmark Sweden AB supports physicians and other healthcare professionals to detect illness independently of the cause and regardless of the symptoms.
Calendar
2024-05-20
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
